Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

Get Instant Summarized Text (Gist) Genetically modified natural killer (NK) cells have shown potential in cancer immunotherapy by overcoming tumor defenses. Using CRISPR/Cas9, researchers ...

Dendritic cells (DC) 'prime' tumor antigen-specific cytotoxic T lymphocytes; thus, we investigated whether DC might also trigger the innate, NK cell-mediated anti-tumor immunity. In mice with MHC ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

which we believe will be major catalysts for the company by providing early proof-of-concept on the CAR-NK cell approach in autoimmune diseases,” the analysts said in a March 27 note.